Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

NCT00908024 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Head and Neck Cancer
Neoplasm Metastasis

Interventions

DRUG: BMS-754807
DRUG: cetuximab (Erbitux®)

Sponsor

Bristol-Myers Squibb